Cellusion Raises 1.1B JPY to Advance Japan and Global Clinical Trials of CLS001 for Corneal Endothelial Cell Regenerative Therapy
TOKYO--(BUSINESS WIRE)--#Asia--Cellusion Inc., a regenerative medicine startup aiming to solve the global Corneal transplant waiting…